Fidelity Investments
ARLZ

Fidelity Investments’s Aralez Pharmaceuticals Inc. ARLZ Stock Holding History

Fidelity Investments’s Portfolio ARLZ Stock Details ARLZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-266,469
Closed -$360K – 2705
2017
Q2 		$360K Sell
266,469
-7,000
-3% -$10.1K ﹤0.01% 2532
2017
Q1 		$585K Buy
273,469
+199
+0.1% +$748 ﹤0.01% 2516
2016
Q4 		$1.21M Hold
273,270
– – ﹤0.01% 2448
2016
Q3 		$1.32M Hold
273,270
– – ﹤0.01% 2424
2016
Q2 		$902K Hold
273,270
– – ﹤0.01% 2486
2016
Q1 		$970K Buy
+273,270
New +$1.41M ﹤0.01% 2482

Other funds holding ARLZ

PCM
PAR Capital Management Boston, Massachusetts $3.44B AUM 28.5% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
JAM
JW Asset Management Miami Beach, Florida $244M AUM 71.51% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $501B AUM 22.01% 1-Year Est. Return
CIM
Contrarius Investment Management St. Helier, Jersey $1.76B AUM 35.87% 1-Year Est. Return
BAS
Brown Advisory Securities Baltimore, Maryland $27.3M AUM 10.67% 1-Year Est. Return